Lisata Therapeutics (LSTA) News Today → Biden FINISHED On June 13th? (From Paradigm Press) (Ad) Free LSTA Stock Alerts $2.96 +0.19 (+6.86%) (As of 05/14/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 10, 2024 | markets.businessinsider.comPositive Outlook for Lisata Therapeutics as Analyst Reaffirms Buy Rating Amid Strong Financials and Promising Clinical TrialsMay 10, 2024 | finance.yahoo.comQ1 2024 Lisata Therapeutics Inc Earnings CallMay 10, 2024 | finance.yahoo.comLisata Therapeutics, Inc. (NASDAQ:LSTA) Q1 2024 Earnings Call TranscriptMay 9, 2024 | proactiveinvestors.comLisata Therapeutics reports strong 1Q performance, cash to support operations into 2026May 9, 2024 | globenewswire.comLisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 8, 2024 | finance.yahoo.comLisata Therapeutics to Participate in Upcoming May 2024 Industry and Investor EventsMay 8, 2024 | americanbankingnews.comLisata Therapeutics (LSTA) to Release Quarterly Earnings on ThursdayMay 2, 2024 | globenewswire.comLisata Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update on Thursday, May 9, 2024April 26, 2024 | markets.businessinsider.comSell Rating on Sage Therapeutics Amid Zurzuvae Sales Concerns and Pipeline RisksApril 25, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Lisata Therapeutics (LSTA) and SAGE Therapeutics (SAGE)April 23, 2024 | finance.yahoo.comLisata Therapeutics advances lead asset LSTA1 for treatment of advanced solid tumorsApril 23, 2024 | finance.yahoo.comLisata Therapeutics and Qilu Pharmaceutical Announce First Patient Treated in Qilu’s Phase 2 Trial in China of LSTA1 in Patients with Metastatic Pancreatic Ductal AdenocarcinomaApril 23, 2024 | globenewswire.comLisata Therapeutics and Qilu Pharmaceutical Announce First Patient Treated in Qilu's Phase 2 Trial in China of LSTA1 in Patients with Metastatic Pancreatic Ductal AdenocarcinomaApril 11, 2024 | finanznachrichten.deLisata Therapeutics, Inc.: Lisata Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to LSTA1 for the Treatment of OsteosarcomaApril 9, 2024 | markets.businessinsider.comLisata Receives FDA Orphan Drug Designation For LSTA1 To Treat OsteosarcomaApril 9, 2024 | globenewswire.comLisata Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to LSTA1 for the Treatment of OsteosarcomaApril 3, 2024 | globenewswire.comLisata Therapeutics to Participate in Upcoming April 2024 Industry and Investor EventsMarch 21, 2024 | msn.comLisata gets FDA rare pediatric disease status for lead drugMarch 21, 2024 | markets.businessinsider.comLisata's LSTA1 Gets Rare Pediatric Disease Designation From FDA For OsteosarcomaMarch 21, 2024 | globenewswire.comLisata Therapeutics Announces U.S. FDA Rare Pediatric Disease Designation Granted to LSTA1 for the Treatment of OsteosarcomaMarch 15, 2024 | finance.yahoo.comHere's Why We're Watching Lisata Therapeutics' (NASDAQ:LSTA) Cash Burn SituationMarch 4, 2024 | financialpost.comLisata Therapeutics to Present at the Life Science Investor Forum on March 7ᵗʰMarch 2, 2024 | seekingalpha.comLisata Therapeutics, Inc. (LSTA) Q4 2023 Earnings Call TranscriptMarch 2, 2024 | finance.yahoo.comLisata Therapeutics, Inc. (NASDAQ:LSTA) Q4 2023 Earnings Call TranscriptMarch 1, 2024 | finanznachrichten.deLisata Therapeutics, Inc.: Lisata Therapeutics Reports Full Year 2023 Financial Results and Provides Business UpdateMarch 1, 2024 | finance.yahoo.comQ4 2023 Lisata Therapeutics Inc Earnings CallFebruary 29, 2024 | benzinga.comRecap: Lisata Therapeutics Q4 EarningsFebruary 29, 2024 | globenewswire.comLisata Therapeutics Reports Full Year 2023 Financial Results and Provides Business UpdateFebruary 28, 2024 | benzinga.comLisata Therapeutics's Earnings OutlookFebruary 22, 2024 | globenewswire.comLisata Therapeutics to Host Year-End 2023 Conference Call on Thursday, February 29, 2024 at 4:30 p.m. Eastern TimeFebruary 20, 2024 | finance.yahoo.comLisata Therapeutics to Present at BIO CEO & Investor ConferenceFebruary 20, 2024 | globenewswire.comLisata Therapeutics to Present at BIO CEO & Investor ConferenceJanuary 18, 2024 | msn.comLisata Therapeutics treats first patient in Phase IIa trial of LSTA1 drugJanuary 17, 2024 | finance.yahoo.comLisata Therapeutics Announces First Patient Treated in the Phase 2a Trial of LSTA1 in Patients with Glioblastoma MultiformeJanuary 5, 2024 | markets.businessinsider.comBuy Rating Affirmed for Lisata Therapeutics on Strong Clinical Prospects for LSTA1January 4, 2024 | finance.yahoo.comLisata Therapeutics Announces Publication of Case Report on a Complete Response in a Metastatic Gastroesophageal Adenocarcinoma Patient Treated with LSTA1 in Combination with Standard-of-Care TherapyDecember 13, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Aslan Pharmaceuticals (ASLN), Lisata Therapeutics (LSTA) and Oric Pharmaceuticals (ORIC)December 12, 2023 | finance.yahoo.comLisata Therapeutics Announces Completion of Enrollment in Phase 2b ASCEND Trial of LSTA1 in Metastatic Pancreatic Ductal AdenocarcinomaDecember 9, 2023 | morningstar.comLisata Therapeutics Inc LSTANovember 28, 2023 | finance.yahoo.comLisata Therapeutics to Present at NobleCon19 Investor ConferenceNovember 9, 2023 | finance.yahoo.comLisata Therapeutics Announces Participation in Upcoming Conferences in NovemberNovember 7, 2023 | finance.yahoo.comAll You Need to Know About Lisata Therapeutics, Inc. (LSTA) Rating Upgrade to BuyNovember 5, 2023 | finance.yahoo.comLisata Therapeutics, Inc. (NASDAQ:LSTA) Q3 2023 Earnings Call TranscriptNovember 3, 2023 | markets.businessinsider.comStrong Financials and Advancements in Clinical Trials Bolster Buy Rating for Lisata TherapeuticsNovember 3, 2023 | finance.yahoo.comQ3 2023 Lisata Therapeutics Inc Earnings CallNovember 2, 2023 | finance.yahoo.comLisata Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business UpdateNovember 1, 2023 | benzinga.comEarnings Preview: Lisata TherapeuticsOctober 26, 2023 | finance.yahoo.comLisata Therapeutics to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 2nd at 4:30 p.m. Eastern TimeOctober 24, 2023 | finance.yahoo.comLisata Therapeutics Announces First Patient Treated in the Cholangiocarcinoma Cohort of the BOLSTER Trial of LSTA1, a Novel Tumor-Targeting and Penetrating PeptideOctober 18, 2023 | msn.comLisata's (LSTA) Lead Cancer Drug Gets EC's Orphan Tag, Stock Up Get Lisata Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LSTA and its competitors with MarketBeat's FREE daily newsletter. Email Address Did Intel Just Dethrone Nvidia? (Ad)Intel (INTC) just announced a brand-new AI venture - the Aurora supercomputer. This computer was specifically designed for artificial intelligence and is now the fastest AI-centered computer on the planet. You can get all the details here. LSTA Media Mentions By Week LSTA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LSTA News Sentiment▼0.930.56▲Average Medical News Sentiment LSTA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LSTA Articles This Week▼101▲LSTA Articles Average Week Get Lisata Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LSTA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TherapeuticsMD News Today Bullfrog AI News Today CytoMed Therapeutics News Today Cumberland Pharmaceuticals News Today RenovoRx News Today Lumos Pharma News Today Synlogic News Today Qilian International Holding Group News Today Benitec Biopharma News Today Sol-Gel Technologies News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LSTA) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable ProsperityRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe only AI company you should be looking atBehind the MarketsElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lisata Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
